- Email: [email protected]
Pall seals ATMI LifeSciences purchase
NEWS of BluMetric’s near-term financial strategy. “This consolidation of activity on the Carp Road figures prominently in the area business association’s ‘Cleantech in the Carp Road Corridor’ initiative,” said BluMetric co-CEO Roger Woeller. “For BluMetric, the move of our Ottawa activities to one location will result in significant operational efficiencies. It brings together our divisional engineering, project management, and corporate financial groups, which will improve internal communication.” Business Development Bank Canada provided financing assistance through a C$700 000 mortgage, with repayment over 15 years. For further information, visit www.blumetric.ca
Bluewater Bio signs reciprocal licensing agreement with Biowater
B
luewater Bio International has entered into an agreement with Norway-based Biowater Technology to market each other’s advanced, high rate filtration and Moving Bed Bio Reactor (MBBR) processes. The agreement covers Bluewater Bio’s FilterClear and Biowater’s CFIC products on a global, non-exclusive basis. The agreement marks the culmination of an increasingly close relationship over the past 18 months, including the co-installation of Bluewater Bio’s FilterClear and Biowater’s CMFF technologies on a water reuse system for the Nirlon ‘green campus’, near Mumbai, India. In addition to technology supply, both companies will provide, where necessary, relevant training and support. Audun Lodemel, CEO of Biowater Technology, said: “We are looking forward to working with Bluewater Bio in what is undoubtedly a mutually beneficial alliance between two companies that share the same vision and values. The combination of Bluewater’s high rate media filter with our own low footprint, cost effective biofilm technologies, such as the next generation Continuous Flow Intermittent Cleaning MBBR (CFIC), allows us to address an even wider segment of the market – both municipal and industrial. Likewise, Bluewater Bio is well placed to benefit from the utilisation of our technologies to their 4
Filtration Industry Analyst
global network. Customers will benefit from the combined solution with lower investment and operation costs.” Daniel Ishag, founder and CEO of Bluewater Bio International, added: “We view Biowater as an important strategic partner going forward, as we look to consolidate our market position globally whilst opening up the new opportunities that Biowater’s technology portfolio affords us.” For further information, visit www.bluewaterbio.com and www.biowatertechnology.com
Osmoflo forms wastewater business
A
ustralian water solutions and desalination company Osmoflo has set up a wastewater business to serve increasing demand from industry and the utilities sector for efficient wastewater treatment systems that maximise water reuse. Osmoflo’s wastewater business will offer a full range of wastewater treatment systems in addition to membrane-based technologies. Contract options include engineering, procurement and construction (EPC); design, build, operate and maintain (DBOM); build, own and operate (BOO); rental; and commercial lease. The wastewater business will be based at Osmoflo’s manufacturing facility in Burton, South Australia with technical representatives located at the company’s offices throughout Australia. “Osmoflo has wide Australian and international experience in provision of plants enabling reuse or the discharge of treated water in full compliance with regulatory standards however the new business signifies a dedicated approach within the company to wastewater management, one that we believe industry has come to expect from providers of water solutions” said Jamie Roodenrys, Osmoflo manager, wastewater. “Demand for reuse is being driven by growing community and industry expectations relating to sustainable, cost effective and reliable wastewater treatment coupled with the implementation of increasingly stringent regulatory standards particularly relating to environmental discharge. These factors are bringing about a renewed focus on all aspects of wastewater treatment and recycling.” For further information, visit www.osmoflo.com.au
Pall seals ATMI LifeSciences purchase
P
all Corp has completed the acquisition of ATMI Inc’s LifeSciences business (see Filtration Industry Analyst, January 2014). The ATMI LifeSciences portfolio acquired by Pall encompasses custom-engineered, flexible packaging solutions, single-use storage systems, mixers and bioreactors for the pharmaceutical and biopharmaceutical industries. This includes brands such as Integrity single-use technologies and Newform ultra clean sterile packaging. “The acquisition of ATMI LifeSciences broadens our upstream presence in bioprocessing and complements our established downstream capabilities,” said Larry Kingsley, Pall chairman and CEO. “Combined with the recent acquisitions of single-use innovators Medistad Holding BV and SoloHill Engineering Inc and our already solid portfolio of biopharmaceutical solutions, the addition of the ATMI LifeSciences assets positions us well to capitalise on opportunities in the rapidly growing single-use market segment.”
For further information, visit www.pall.com, www.atmi.com and www.atmi-lifesciences.com
Polymer Group invests in Waynesboro facility
P
olymer Group Inc (PGI) is to spend US$8 million upgrading machinery and expanding its manufacturing plant in Waynesboro, Virginia, USA. By the end of this year’s second quarter, PGI will refurbish more than 20 000 sq ft of the Waynesboro facility, upgrade an existing R&D machine used to create proprietary filtration technology, install two additional assets and improve the existing quality lab with state-of-the-art equipment. PGI will also hire up to 20 new employees at the facility. Once the investment is complete, PGI will be able to produce every component needed to make synthetic composites for enhanced mechanical filtration applications. Using these synthetic composites, PGI will initially target the HVAC, facemask, fluid power and automotive cabin air markets.
For further information, visit www.polymergroupinc.com
February 2014
Bluewater Bio signs reciprocal licensing agreement with Biowater
B
luewater Bio International has entered into an agreement with Norway-based Biowater Technology to market each other’s advanced, high rate filtration and Moving Bed Bio Reactor (MBBR) processes. The agreement covers Bluewater Bio’s FilterClear and Biowater’s CFIC products on a global, non-exclusive basis. The agreement marks the culmination of an increasingly close relationship over the past 18 months, including the co-installation of Bluewater Bio’s FilterClear and Biowater’s CMFF technologies on a water reuse system for the Nirlon ‘green campus’, near Mumbai, India. In addition to technology supply, both companies will provide, where necessary, relevant training and support. Audun Lodemel, CEO of Biowater Technology, said: “We are looking forward to working with Bluewater Bio in what is undoubtedly a mutually beneficial alliance between two companies that share the same vision and values. The combination of Bluewater’s high rate media filter with our own low footprint, cost effective biofilm technologies, such as the next generation Continuous Flow Intermittent Cleaning MBBR (CFIC), allows us to address an even wider segment of the market – both municipal and industrial. Likewise, Bluewater Bio is well placed to benefit from the utilisation of our technologies to their 4
Filtration Industry Analyst
global network. Customers will benefit from the combined solution with lower investment and operation costs.” Daniel Ishag, founder and CEO of Bluewater Bio International, added: “We view Biowater as an important strategic partner going forward, as we look to consolidate our market position globally whilst opening up the new opportunities that Biowater’s technology portfolio affords us.” For further information, visit www.bluewaterbio.com and www.biowatertechnology.com
Osmoflo forms wastewater business
A
ustralian water solutions and desalination company Osmoflo has set up a wastewater business to serve increasing demand from industry and the utilities sector for efficient wastewater treatment systems that maximise water reuse. Osmoflo’s wastewater business will offer a full range of wastewater treatment systems in addition to membrane-based technologies. Contract options include engineering, procurement and construction (EPC); design, build, operate and maintain (DBOM); build, own and operate (BOO); rental; and commercial lease. The wastewater business will be based at Osmoflo’s manufacturing facility in Burton, South Australia with technical representatives located at the company’s offices throughout Australia. “Osmoflo has wide Australian and international experience in provision of plants enabling reuse or the discharge of treated water in full compliance with regulatory standards however the new business signifies a dedicated approach within the company to wastewater management, one that we believe industry has come to expect from providers of water solutions” said Jamie Roodenrys, Osmoflo manager, wastewater. “Demand for reuse is being driven by growing community and industry expectations relating to sustainable, cost effective and reliable wastewater treatment coupled with the implementation of increasingly stringent regulatory standards particularly relating to environmental discharge. These factors are bringing about a renewed focus on all aspects of wastewater treatment and recycling.” For further information, visit www.osmoflo.com.au
Pall seals ATMI LifeSciences purchase
P
all Corp has completed the acquisition of ATMI Inc’s LifeSciences business (see Filtration Industry Analyst, January 2014). The ATMI LifeSciences portfolio acquired by Pall encompasses custom-engineered, flexible packaging solutions, single-use storage systems, mixers and bioreactors for the pharmaceutical and biopharmaceutical industries. This includes brands such as Integrity single-use technologies and Newform ultra clean sterile packaging. “The acquisition of ATMI LifeSciences broadens our upstream presence in bioprocessing and complements our established downstream capabilities,” said Larry Kingsley, Pall chairman and CEO. “Combined with the recent acquisitions of single-use innovators Medistad Holding BV and SoloHill Engineering Inc and our already solid portfolio of biopharmaceutical solutions, the addition of the ATMI LifeSciences assets positions us well to capitalise on opportunities in the rapidly growing single-use market segment.”
For further information, visit www.pall.com, www.atmi.com and www.atmi-lifesciences.com
Polymer Group invests in Waynesboro facility
P
olymer Group Inc (PGI) is to spend US$8 million upgrading machinery and expanding its manufacturing plant in Waynesboro, Virginia, USA. By the end of this year’s second quarter, PGI will refurbish more than 20 000 sq ft of the Waynesboro facility, upgrade an existing R&D machine used to create proprietary filtration technology, install two additional assets and improve the existing quality lab with state-of-the-art equipment. PGI will also hire up to 20 new employees at the facility. Once the investment is complete, PGI will be able to produce every component needed to make synthetic composites for enhanced mechanical filtration applications. Using these synthetic composites, PGI will initially target the HVAC, facemask, fluid power and automotive cabin air markets.
For further information, visit www.polymergroupinc.com
February 2014